A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 195,634 shares of DHR stock, worth $48.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
195,634
Previous 189,184 3.41%
Holding current value
$48.9 Million
Previous $43.8 Million 11.63%
% of portfolio
0.07%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$224.58 - $256.19 $1.45 Million - $1.65 Million
6,450 Added 3.41%
195,634 $48.9 Million
Q4 2023

Jan 16, 2024

SELL
$185.1 - $233.13 $1.56 Million - $1.96 Million
-8,415 Reduced 4.26%
189,184 $43.8 Million
Q3 2023

Oct 24, 2023

SELL
$233.08 - $265.59 $417,912 - $476,202
-1,793 Reduced 0.9%
197,599 $49 Million
Q2 2023

Jul 25, 2023

SELL
$224.99 - $256.14 $672,495 - $765,602
-2,989 Reduced 1.48%
199,392 $47.9 Million
Q1 2023

Apr 14, 2023

BUY
$239.75 - $277.0 $2.76 Million - $3.19 Million
11,499 Added 6.02%
202,381 $51 Million
Q4 2022

Feb 08, 2023

SELL
$241.42 - $282.29 $7.74 Million - $9.05 Million
-32,044 Reduced 14.37%
190,882 $50.7 Million
Q3 2022

Oct 25, 2022

BUY
$247.06 - $1507.4 $1.16 Million - $7.05 Million
4,680 Added 2.14%
222,926 $57.6 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $291,408 - $368,282
1,229 Added 0.57%
218,246 $55.3 Million
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $4.48 Million - $5.5 Million
-17,403 Reduced 7.42%
217,017 $63.7 Million
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $1.33 Million - $1.49 Million
-4,541 Reduced 1.9%
234,420 $77.1 Million
Q3 2021

Nov 02, 2021

SELL
$272.21 - $332.43 $3.87 Million - $4.73 Million
-14,223 Reduced 5.62%
238,961 $72.8 Million
Q2 2021

Aug 11, 2021

SELL
$225.08 - $271.69 $615,368 - $742,800
-2,734 Reduced 1.07%
253,184 $67.9 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $2.17 Million - $2.51 Million
10,209 Added 4.15%
255,918 $57.6 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $1.31 Million - $1.51 Million
-6,161 Reduced 2.45%
245,709 $54.6 Million
Q3 2020

Nov 04, 2020

BUY
$177.16 - $215.33 $6.42 Million - $7.8 Million
36,214 Added 16.79%
251,870 $54.2 Million
Q2 2020

Jul 17, 2020

BUY
$128.7 - $176.83 $708,622 - $973,625
5,506 Added 2.62%
215,656 $38.1 Million
Q1 2020

Apr 21, 2020

BUY
$121.39 - $169.05 $1.5 Million - $2.09 Million
12,374 Added 6.26%
210,150 $29.1 Million
Q4 2019

Feb 12, 2020

SELL
$133.47 - $153.48 $2.15 Million - $2.48 Million
-16,137 Reduced 7.54%
197,776 $30.4 Million
Q3 2019

Nov 07, 2019

BUY
$135.4 - $146.47 $2.59 Million - $2.8 Million
19,096 Added 9.8%
213,913 $30.9 Million
Q2 2019

Aug 06, 2019

BUY
$124.88 - $143.73 $215,293 - $247,790
1,724 Added 0.89%
194,817 $27.8 Million
Q1 2019

May 06, 2019

BUY
$97.62 - $132.29 $3.98 Million - $5.39 Million
40,732 Added 26.73%
193,093 $25.5 Million
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $1.98 Million - $2.29 Million
20,919 Added 15.92%
152,361 $15.7 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $1.41 Million - $1.56 Million
14,358 Added 12.26%
131,442 $14.3 Million
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $2.28 Million - $2.45 Million
23,760 Added 25.46%
117,084 $11.6 Million
Q1 2018

Apr 16, 2018

BUY
$92.16 - $103.8 $1.85 Million - $2.08 Million
20,063 Added 27.39%
93,324 $9.14 Million
Q4 2017

Feb 09, 2018

BUY
$85.26 - $94.62 $231,907 - $257,366
2,720 Added 3.86%
73,261 $6.8 Million
Q3 2017

Oct 26, 2017

BUY
$79.29 - $88.45 $94,592 - $105,520
1,193 Added 1.72%
70,541 $6.05 Million
Q2 2017

Aug 15, 2017

BUY
N/A
69,348
69,348 $5.85 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $182B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.